Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
about
Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysisThe efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.Rituximab for children with immune thrombocytopenia: a systematic review.Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series.Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.Brain abscess following rituximab infusion in a patient with pemphigus vulgaris.Disseminated Enteroviral Infection Associated with Obinutuzumab.Rituximab-related viral infections in lymphoma patients.Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000.The late adverse events of rituximab therapy--rare but there!Urban legends: pemphigus vulgaris.Systemic treatment of vitreous inflammation.Systemic treatments for noninfectious vitreous inflammation.Orofacial adverse effects of biological agents.Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.A Case of Fulminant Hepatitis due to Echovirus 9 in a Patient on Maintenance Rituximab Therapy for Follicular Lymphoma.Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.Rituximab therapy for primary glomerulonephritis: Report on two casesFatal case of enterovirus 71 infection and rituximab therapy, france, 2012.Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy.Monoclonal antibodies and cytomegalovirus infections.Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab.Enteroviral Encephalitis in a Child With CNS Relapse of Burkitt Leukemia Treated With Rituximab.Persistent antibody depletion after rituximab in three children with autoimmune cytopenias.
P2860
Q30500238-67F65A35-9A24-44AF-83C5-B38A3D22FF3FQ33360255-CEF7C114-DCD3-4189-8AE6-248609AD1C52Q33367239-49E99F06-626F-4030-AB7F-E913C44765F8Q33401605-D3D52CCC-6B19-481A-A75F-AA464110A938Q33681901-1A182ADC-0750-48A8-8DEE-02B9DED40719Q33980153-D5E69021-9E2E-4C2A-BD32-227367DE1B44Q34992090-1CF6EFD2-8128-4244-A322-7F1021D07D90Q35094334-19601EA6-6ABB-4264-B503-7A8D39B873E6Q35997459-144E9A5D-5DF0-4105-AFB0-B025EDB93EADQ36871718-45C9914C-5441-48F9-BA13-33512D183ADFQ36891864-CAEDB62A-EF50-4B77-922F-9743AF413D60Q37462485-1F2E916B-1FF2-4C0F-BDD9-C084D8D57340Q37984131-AC07D01B-1C03-48EE-A192-801E1B439BF6Q38048774-65643F9D-CC4D-47D1-A3FC-A273C57F5970Q38172090-20C14FE1-B4C7-465F-AA8A-96733488B199Q38213692-00FE8151-3371-4462-834C-CB71C4462A2BQ38842494-6C661188-88A9-4D70-A937-3972C349187CQ38992084-0FCD3D35-52A3-43B8-9BA2-CD45384CE15FQ40044232-5F5F1483-6C55-4D66-8D55-9771ED8BA812Q41036642-C080CFB5-5983-4A9F-AACC-C8C5A829DD40Q42548719-3283EAE1-3654-4293-A9AD-59253596FD2BQ43414453-B665660B-7D5C-4DDE-9663-3621B5C6BA51Q43514931-F90F194D-3C7A-4584-A48E-363D6EC977A6Q46725931-028A793E-46E3-45C1-9377-DC44267DD0CCQ46906770-54CDDCF8-E204-4235-82CD-6673552D32E4Q47556669-A9E70569-9E15-45A7-AC36-936908E33E97Q54423024-AB006A41-6954-40FC-9946-73DD5BBD2CC6
P2860
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
@ast
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
@en
type
label
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
@ast
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
@en
prefLabel
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
@ast
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
@en
P2093
P50
P356
P1476
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
@en
P2093
Christine Archimbaud
Hélène Peigue-Lafeuille
Leila Lazaro
Marc Tardieu
Olivier Tournilhac
Pascale Millet
Philippe Travade
Stéphane Blanche
P356
10.1086/345746
P407
P577
2003-01-16T00:00:00Z